Toleranzia appoints Thomas Pålsson as new Chief Financial Officer
16 October - 2023
Toleranzia AB ("Toleranzia" or the "Company") announces today that Thomas Pålsson has been appointed as new Chief Financial Officer (CFO). Thomas, who brings extensive financial and economic expertise from leading roles in Life Science companies, will assume the position as Toleranzia's CFO on October 30, 2023. Thomas succeeds the Company's outgoing CFO, Torbjörn Sannerstedt.
Thomas Pålsson has 25 years of experience as CFO and Business Controller in Life Science companies and almost 15 years of experience as CFO in listed companies. Previous clients include Albireo AB, Arexis AB, and Integrum AB, while current other CFO assignments include CirChem AB, Monivent AB and Stayble Therapeutics AB. Thomas' solid background includes a Master of Business Administration (MBA) degree from the Gothenburg School of Economics.
"I am pleased to welcome Thomas Pålsson to the role as CFO and member of the management team of Toleranzia. Thomas' broad experience in financial analysis together with his operational experience in Life Science companies will strengthen our team and I am very much looking forward to working with him. At the same time, I would like to thank Torbjörn Sannerstedt for his efforts for the Company during his time as CFO", comments Charlotte Fribert, CEO of Toleranzia.
For further information, please contact:
Charlotte Fribert – CEO, Toleranzia AB
Tel: +46 763 19 98 98
About Toleranzia AB (publ)
Toleranzia AB (publ) develops drugs that harness the power of the immune system for the treatment of autoimmune orphan diseases. The drugs, which target the cause of the disease, can cure or significantly alleviate the disease and not, like current treatments, merely reduce the symptoms. They have the potential to be the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. Toleranzia's shares are listed on the Nasdaq First North Growth Market and Mangold Fondkommission AB, 08-503 015 50, CA@mangold.se, is the company's Certified Adviser.